ADMA Biologics, Inc. (ADMA)
NASDAQ·Healthcare·Biotechnology
$11.16
—
Mkt Cap $2.39B
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (10 analysts)
$18.67
Range $17.00 – $21.00
Implied Upside
+67.4%
Consensus $18.67 vs current $11.16
NASDAQ·Healthcare·Biotechnology
$11.16
—
Mkt Cap $2.39B
Buy
3
Hold
0
Sell
0
Price Target (10 analysts)
$18.67
Range $17.00 – $21.00
+67.4%
Consensus $18.67 vs current $11.16